Myval Heart Valve System for Aortic Valve Stenosis
MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Prof. Dr. med. Ingo Eitel · Other
This trial is looking for patients who need treatment with the Myval heart valve. Participants will help researchers evaluate how well this new valve works and how long it lasts.
You may be able to join if
- I need to be treated with the Myval heart valve
- I am at least 18 years old
- I am able to give informed consent
You may not be able to join if
- I am pregnant or breastfeeding
- I have allergies to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum, or any contrast media
- I cannot take anti-platelet or anticoagulant medications
- I have another condition that makes it unsafe for me to participate
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityRational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.
Loading trial locations…
Christian Frerker, PD Dr.
CONTACT